L20: Recreational Drugs Flashcards

1
Q

What are the two types of dependence? Describe them

A
  • Psychological dependence: desire to repeat the rewarding effect of a drug (craving); desire to avoid the physical or psychological effects of drug abstinence; can be triggered by environmental cues
  • Physical dependence: drug abstinence or withdrawal has adverse physiological effect; pharmacological treatment can alleviate some symptoms; shorter lasting and has less impact on relapse than psychological dependence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is tolerance?

A

Decreased effect following repeat administration of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is addiction?

A

drug taking becomes compulsive and dominates lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the classes of commonly abused recreational substances? What are their examples?

A
  • Opioids: morphine, codeine, methadone, diamorphine
  • Stimulants: nicotine, amohetamines, cocaine, MDMA (ecstasy)
  • CNS Depressants: alcohol, barbiturates, ketamine, solvents
  • Psychotomimetics: lysergic acid diethylamide (LSD) and psilocybin, cannabis, phencyclidine (PCP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the examples of ‘very strong’, ‘strong’, ‘weak’ and ‘weak or none’ dependence of drugs?

A
  • Very strong: morphine, heroin, methadone, nicotine, cocaine
  • Strong: amphetamine, ethanol, ketamine
  • Weak: cannabis
  • Weak or none: LSD, MDMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which neurotransmitter pathway and receptor do opiates target?

A

Neurotransmitter: endorphins
Receptor: mu and sigma opioid agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which neurotransmitter pathway and receptor does nicotine target?

A

Neurotransmitter: Acetylcholine
Receptor: alpha-2 beta-4 nAChR agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which neurotransmitter pathway and receptor do aphetamines target?

A

Neurotransmitter: Dopamine
Receptor: Dopamine transporter - reverse transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which neurotransmitter pathway and receptor does cocaine target?

A

Neurotransmitter: dopamine
Receptor: dopamine transporter antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which neurotransmitter pathway and receptor does MDMA target?

A

Neurotransmitter: dopamine, noradrenaline, serotonin
Receptor: monoamine transporter substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which neurotransmitter pathway and receptor does LSD target?

A

Neurotransmitter: serotonin
Receptor: serotonin receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which neurotransmitter pathway and receptor does Cannabis target?

A

Neurotransmitter: endocannabinoids
Receptor: CB1 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which neurotransmitter pathway and receptor does ethanol target?

A

Neurotransmitter: GABA and glutamate
Receptor: GABAa agonist and NMDA receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which neurotransmitter pathway and receptor does PCP and ketamine target?

A

Neurotransmitter: glutamate
Receptor: NMDA receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

On which neurotransmitter do most pathways converge on? What are the functions of this pathway?

A

Dopamine
Functions:
- reward (motivation)
- pleasure (euphoria)
- compulsion
- perseveration
- motor function (fine-tuning)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the common feature of dependence-inducing drugs?

A

The activation of the mesolimbic dopaminergic pathway

16
Q

What are the two types of dopamine receptors? Are they inhibitory or excitatory?

A

D1 dopamine receptor - excitatory
D2 dopamine receptor - inhibitory

17
Q

Where does the mesolimbic dopaminergic pathway originate?

A

Pathway originates in substantia nigra and ventral tegmental area, afterwards sends signal to amygdala (prefrontal cortex)

18
Q

How do drugs of abuse increase dopamine transmission in the nucleus accumbens (NA)?

A

via:
- decreased GABAergic inhibition in VTA (preventing inhibition, more dopamine released)
- increased DA release
- decreased DA reuptake (uptake mechanism blocked, more DA in the synapse)

19
Q

Describe opioids (give examples, what are their structural similarities; what are they derived from; what is their effect)

A
  • morphine, heroin, codeine
  • Morphine and codeine are derived from the sap of opium poppy seedpod
  • Heroin (diamorphine) is synthesized from morphine and is converted into morphine in the body
  • causes intense rush, euphoria, relaxation
  • desire to repeat this rewarding experience leads to tolerance and dependence
20
Q

Why does dependence and tolerance on opioids develope?

A
  • opioid receptors might be lost due to frequent use (GPCRs), rapid dependence as more opioid is needed.
  • Downregulation of cAMP pathway in locus coeruleus neurons (noradrenergic) occurs as tolerance and dependence of opiates develops.
21
Q

What are the symptoms of opioid withdrawals?

A

Anxiety, insomnia, muscle aches, sweating, shivering, abdominal cramping, diarrhoea, dilated pupils, nausea and vomiting

22
Q

What is used for treatment of opioid dependence? Why? How does it work?

A

Methadone
- synthetic opioid with a longer half-life than morphine or heroin
- can stabilise heroin users during drug withdrawal (no rapid drop)
- a long lasting withdrawal from methadone also occurs but less intense
- also an NMDA receptor antagonist

Naltrexone
- opiate competitive antagonist can help recovering addicts from relapsing by preventing rewarding effects

23
Q

Describe nicotine (receptors that it binds to, mechanism of action and effects)

A
  • stimulant
  • binds to nicotinic acetylcholine receptors
  • activates ligand gated ion channel to depolarize neuronal membrane
  • effects in brain complex combination of inhibition and excitation
  • by binding directly to receptor, directly depolarizes membranes and increases dopamine release
24
What kind of dependence and addiction does **nicotine** lead to?
Tolerance and strong dependence with very strong **psychological dependence** leading to addiction
25
What can help reduce cravings and withdrawal symptoms of **nicotine**?
**Nicotine replacement therapy** can help alleviate withdrawal symptoms and reduce cravings **Varenicline** - partial agonist at the alpha-4 beta-2 nAChR - impairs efficacy of nicotine and reduces effect
26
Describe the effects of **cocaine and amphetamines** (tolerance, dependence)
- locomotor stimulation - euphoria and excitement - insomnia - increased stamina - anorexia - anxiety - irritability - restlessness **Tolerance** to amphetamine develops to some effects more readility than others. Tolerance to cocaine is less likely. **Psychological dependence** occurs due to desire to repeat experience Little evidence of **physical dependence** or **withdrawal syndrome**
27
How does **cocaine** act?
Increase **synaptic dopamine** and **noradrenaline** via **blocking reuptake by transporters**. Behavioral effects likely due to increased dopamine. Binds to DA transporters, blocks them, accumulation of DA in synaptic cleft.
28
What could be used as a **target** for **cocaine** and **opioids** addiction treatment?
- **K+ channels** as targets for treatment. - activation of **G-protein coupled inwardly rectifying K+ (GIRK)** channels is a common mechanism of many reward pathways - **cocaine and opioids** both reduce **GIRK** currents - re-activating **GIRK channels** may be a mechanism to overcome addiction pathways - **Baclofen** activates **GIRK** and has been used in treatment of alcohol dependence
29
Describe **amphetamines**, how do they act?
Increase **synaptic dopamine** and noradrenaline via **reverse transport** from pre-synaptic terminals. Behavioral effects likely due to **dopamine**, allow **accumulation of DA**.
30
Describe **alcohol (ethanol)** (its mechanism, dependence, withdrawals)
- most common recreational drug - depressant (not dopamine pathways associated), relaxation (dopamine pathway) - increases **GABAa receptor activity** - inhibitory - acts as **NMDA receptor antagonist** - strong dependence and withdrawal symptoms
31
Describe **cannabis** (active components, dependence, mechanism)
- euphoria, relaxation, appetite - **active components**: tetrahydrocannabinol (THC), cannabinadiol (CBD) - CBD promising candidate for treating variety of conditions: anxiety, epilepsy, depression - complex, brain-wide effects (CB1 one of most abundant GPCRs) - THC - partial agonist at CB1/CB2 receptors - lower GABA release indirectly increases dopamine
32
What are the drugs that target other **neurotransmitter systems**? Which systems?
**serotonin pathway** (function: mood, memory processing, sleep, cognition): - ecstasy - LSD + psilocybin
33
Describe **ecstasy** (emotions, tolerance and dependence, mechanism)
- **emotions**: euphoria, decreased anxiety, increased intimacy and sensations, mildly hallucinogenic - tolerance and dependence to **ecstasy** is **uncommon** (due to being a global effect) - ecstasy increases **synaptic serotonin** via **blocking reuptake** by serotonin transporters (false substrate, blocks, sustains reuptake) - similar effects dopamine and noradrenaline transporters.
34
Describe **LSD and Psilocybin** (Tolerance, mechanism, which receptors does it act on)
- psychotomimetic (distorted perception, hallucinations) - tolerance to effects occurs but no physical withdrawal symptoms - in clinical trials for depression, addiction, migraine, cluster headaches - agonist at 5-HT receptors and psychomimetic effects mainly tue to 5-HT2A subtype - inhibits 5-HT neurons in **raphe nuclei** - activating inhibitory autoreceptors